Aplenzin 348 mg/1

Aplenzin 348 mg is an extended-release tablet containing bupropion hydrobromide, used to manage depression and seasonal affective disorder. This medication is designed for oral administration and is manufactured by Bausch Health US, LLC.

Aplenzin 348 mg is primarily used for the management of major depressive disorder (MDD) and seasonal affective disorder (SAD). It works by affecting certain chemicals in the brain that may be unbalanced in people with depression. This medication is often prescribed when other treatments have not been effective or have caused unwanted side effects. Aplenzin 348 mg is also sometimes used to help people stop smoking, although this is not its primary purpose.

Common effects of Aplenzin 348 mg may include dry mouth, nausea, dizziness, and insomnia. Some users may experience headaches or constipation. These effects are usually mild and temporary, but if they persist or worsen, it is important to consult a healthcare provider. Serious side effects are rare but can include seizures, severe allergic reactions, and changes in mood or behavior.

Aplenzin 348 mg should be handled with care and stored in a cool, dry place away from direct sunlight. It is important to follow the prescribed dosage and administration instructions provided by a healthcare professional. This medication should not be crushed, chewed, or broken, as it is designed for extended release. Pregnant or breastfeeding women should consult their healthcare provider before using this medication.

Aplenzin 348 mg may interact with other medications, including those that affect the central nervous system, such as antidepressants, antipsychotics, and seizure medications. It is important to inform your healthcare provider about all medications you are taking, including over-the-counter drugs and supplements. Alcohol should be avoided while taking Aplenzin 348 mg, as it can increase the risk of seizures and other side effects.